GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » 10-Year RORE %

C21 Investments (XCNQ:CXXI) 10-Year RORE % : -4.63% (As of Oct. 2023)


View and export this data going back to 1987. Start your Free Trial

What is C21 Investments 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. C21 Investments's 10-Year RORE % for the quarter that ended in Oct. 2023 was -4.63%.

The industry rank for C21 Investments's 10-Year RORE % or its related term are showing as below:

XCNQ:CXXI's 10-Year RORE % is ranked worse than
67.45% of 639 companies
in the Drug Manufacturers industry
Industry Median: 5.79 vs XCNQ:CXXI: -4.63

C21 Investments 10-Year RORE % Historical Data

The historical data trend for C21 Investments's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments 10-Year RORE % Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 -10.61 0.32 -24.05 -20.38

C21 Investments Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.60 -20.38 -19.57 -6.63 -4.63

Competitive Comparison of C21 Investments's 10-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's 10-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where C21 Investments's 10-Year RORE % falls into.



C21 Investments 10-Year RORE % Calculation

C21 Investments's 10-Year RORE % for the quarter that ended in Oct. 2023 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( -0.041--0.132 )/( -1.964-0 )
=0.091/-1.964
=-4.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Oct. 2023 and 10-year before.


C21 Investments  (XCNQ:CXXI) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


C21 Investments 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of C21 Investments's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments (XCNQ:CXXI) Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 280, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures, and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.

C21 Investments (XCNQ:CXXI) Headlines

No Headlines